Market research
OM Outset Medical Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 79M
- P/E ratio
- Not available
- Analyst target
- 7.6667
- Dividend yield
- Not available
- Beta
- 1.92
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US6901452069
- Market cap
- 79M
- P/E ratio
- Not available
- Analyst target
- 7.6667
- Dividend yield
- Not available
- Beta
- 1.92
About
About Outset Medical Inc
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the OM discussion.
5 years, 4 months ago
From a valuation standpoint, the stock is 98.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 18.6.
Based on the above factors, Outset Medical, Inc gets an overall score of 1/5.